LPS-induced decrease in Sp1 DNA binding activity is associated with an increased NF-κB binding activity. by Xiaobing Ye (49295)

“…(A) and (C): EMSA photographs show that LPS-induced decrease in Sp1 DNA binding activity is associated with an increased NF-κB binding activity.…”

AEA and URB597 decrease cell proliferation without inducing apoptosis. by Laurie Hamtiaux (199349)

Melatonin and hypoxia/reoxygenation decrease the mitochondrial content in BeWo cells. by Lucas Sagrillo-Fagundes (6194843)

Glucagon receptor (GcgR) antagonism decrease α-cell proliferation. by Zhuo Liu (357070)

Silencing AXL in human colon cancer cells does not decrease proliferation. by Diana J. Uribe (2201695)

Alcohol decreases NETosis and NET-mediated bacterial killing in mouse bone marrow-derived neutrophils in response to <i>S</i>. <i>aureus</i> infection. by Liliang Jin (4443058)

Bcl6 deficiency decreases expression of lipogenic genes and proteins in liver. by Christopher R. LaPensee (571785)

Calpain protein expression level and enzyme activity are decreased in calpain mutants. by James B. Reinecke (346003)

SETD2 loss of function in BMSCs showed decreased bone mass. by Lijun Wang (176511)

BBR decreased fasting blood glucose without improvement in insulin sensitivity. by Xuan Xia (356454)

ADAR2 expression is decreased in the islets of JNK1 knockout mice. by Liu Yang (23752)

<i>shk-1</i> mutants display decreased glycogen storage. by Longjun Pu (20685717)

HDAC inhibitor reduced the expression of SGLT1 and decreased glucose uptake. by Chia-Wei Chou (354261)

OPN-deficiency decreases inflammation, oxidative stress and fibrosis in adipose tissue. by Andoni Lancha (335824)

FLZ decreased the expression of BACE1 and did not affect the expression of IDE. by Xiu-Qi Bao (479278)

Aging is associated with decreased fat mass and increased oxidative stress in mice. by Hannes M. Findeisen (353287)

Nilotinib decreases the <i>in vitro</i> tumorigenicity of HEI-193 cells. by Nesrin Sabha (127278)

“…(C) The mean maximal colony diameter was decreased by nilotinib at ≥3 µM in PDGF-BB media, and at ≥5 µM in GM. …”

Decreased Rab10 localization in raft fractions following methamphetamine treatment. by Scott M. Vanderwerf (785324)

The G357S mutation decreases both activation and termination thresholds for SOICR. by Yingjie Liu (317210)

L-NNA treatment decreases tumor blood flow and increases hypoxia. by Robert J. G. Cardnell (350872)

“…Data presented as mean intensity as a percentage of control ± SEM; n = 5; *** = p<0.01. …”